Home / Dangerous Drugs / Zantac® / Case Evaluation

Zantac® Case Evaluation

Learn More About Your Legal Rights

Current status of litigation involving Zantac®
If your injury may be compensable
Protecting your rights and potential claims

Please fill in the form to request a FREE case evaluation from one of our attorneys if you or a loved one have taken Zantac® and subsequently been diagnosed with stomach cancer, breast cancer, bladder cancer, small intestine cancer, colorectal cancer, esophageal cancer, liver cancer, prostate cancer, pancreatic cancer, leukemia, non-Hodgkin’s lymphoma, or multiple myeloma.

First Name: *

Last Name: *

Address:

City:

State: * St: *

Zip:

Home Phone: *

Cell Phone:

Email Address: *

Have you or someone you know taken Zantac® and subsequently been diagnosed with cancer? * Yes No

LEARN MORE ABOUT:

Current status of litigation involving Zantac®
If your injury may be compensable
Protecting your rights and potential claims

All personal information will be kept private. Please read our disclaimer.

Facts About Zantac® and NDMA Contamination

Ranitidine is an oral medication commonly prescribed for the treatment of acid reflux. It was originally approved by the FDA in 1984 under the brand name Zantac®. It is now available in both branded and generic forms both are over-the-counter (OTC) and by prescription.
On September 13, 2019, the U.S. Food and Drug Administration (FDA) released a statement alerting patients and health care professionals about the discovery of the presence of a contaminant N-nitrosodimethylamine (NDMA) in samples of ranitidine commonly known as the brand-name drug Zantac®.
On April 1, 2020, The U.S. Food and Drug Administration announced it was requesting that manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. The agency had determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels of this impurity. As a result of this immediate market withdrawal request, ranitidine products are not available for new or existing prescriptions or OTC use in the U.S.
NDMA is classified as a probable human carcinogen which means that it is more likely than not to cause cancer in humans. NDMA has been studied in animal populations and found to increase the occurrence of cancer in the animals. The studies have raised the specter of an association between NDMA and liver toxicity which can lead to the development of liver cancer and other related conditions brought about by an NDMA-induced “insult” to the liver. Cancers that are linked to NDMA exposure include:
- Stomach Cancer
- Breast Cancer
- Bladder Cancer
- Small Intestine Cancer
- Colorectal Cancer
- Esophageal Cancer
- Liver Cancer
- Prostate Cancer (Under the age of 65)
- Pancreatic Cancer
- Leukemia
- Non-Hodgkin’s Lymphoma
- Multiple Myeloma
The degree and duration of human NDMA exposure that can lead to the development of cancer is not precisely known. Similarly, the extent and duration of the NDMA contamination of Zantac® (ranitidine) are not precisely known. Efforts are underway to define the scope and degree of the NDMA contamination. The FDA reports that “some levels of the impurity [NDMA] may have been in the ranitidine-containing products for as long as four years.”

Your Legal Rights

I or a loved one have been taking Zantac® and have have developed cancer. If you have been taking a Zantac® (ranitidine) medication and been diagnosed with cancer of the stomach, breast, bladder, small intestine, colon/rectum, esophagus, prostate, or pancreas, or with leukemia, Non-Hodgkin’s lymphoma, or multiple myeloma; you may be entitled to compensation for your injuries as well as for any expenses, emotional distress, and inconveniences you have endured as a result of your medical treatment.
Looking for a Lawyer to Represent You? Our attorneys and co-counsel not only have the skill, experience, and expertise to investigate and handle your potential case, but also a proven track record of success in representing people who have been injured by dangerous products.
What is the scope of the Zantac® contamination? This full extent of the contamination is not yet known. The FDA and affected drug manufacturers are still testing raniditine-containing products as well as different batches/lots of these products. The FDA has not yet recalled the medication yet but may in the future.
The Zantac® NDMA contamination in the News – In addition to the FDA’s September statement, several media outlets have recently reported on the contamination of this widely-used drug.
Our attorneys and co-counsel can assist you — If you believe your cancer diagnosis may be associated with your Zantac® (raniditine) medication, please complete the Case Evaluation form on this page and we will review your situation.

Attorney Ron Meneo & The Meneo Law Group

Attorney Ron Meneo manages and leads The Meneo Law Group. Your case will be personally reviewed and evaluated by him. Providing us with information about your case enables us to understand the nature of your injury and its probable cause. This allows us to make our conversation with you as productive as possible.
For the past 15 years, and with a Martindale Hubbell "Preeminent AV Rating" (the highest possible rating in both Legal Ability and Ethical Standards), Attorney Meneo has successfully represented hundreds of clients who have been injured by defective drugs and medical products.
Our commitments to excellence and our diligence are the hallmarks of our practice and guide us in representing each of our clients including those whom we successfully represented in the Diet Drug (fen-phen), PPA, Zyprexa®, Ketek®, YAZ® and Pradaxa® nationwide, mass tort litigations.

Holding Drug and Medical Device Companies Accountable

Too often the true extent and scope of the dangers associated with a particular prescription drug or medical device are hidden from the medical profession and patients. Whether from downplaying the risks or simply ignoring evidence of them, these companies reap billions of dollars in profits at the expense of patient health and safety. When this occurs, these companies must be held accountable.
The power and proclivity of the Food and Drug Administration to hold these companies accountable only extend so far. For individual patients who have been harmed by defective drugs and medical devices, the court system is usually the only pathway for justice.
We have a proven track record of holding drug and medical device manufacturers accountable for injuries sustained by our clients and for monetary damages caused by those injuries.

Financial Consequences of Personal Injury

The financial burdens resulting from personal injury can be substantial and include the costs of hospitalization, surgery, doctors, rehabilitation, physical and occupational therapy, travel, prescription medications and other items. In addition, there is likely pain and suffering and oftentimes a loss of current and future income, of family and spousal consortium, and of the enjoyment of pre-injury activities and mobility. In cases of severe and/or permanent injury, the future costs of care, treatment, maintenance and support can be overwhelming.
Insurance may only go so far in covering these costs and losses. Legal action may be the only way to protect yourself and your family to obtain adequate moneys to address your needs and secure your and your family's future.

Protect Your Rights

Personal injury claims, including those for product liability and negligence, are subject to various statutes of limitation. These laws limit the amount of time within which a claim for monetary damages may be brought against the company or person responsible for the injuries. Consequently, acting promptly to protect your, or a loved one's, legal claims and rights is imperative.
Statutes of limitation vary from state to state. Generally, they can begin to run from either the date of your injury or the date you first discovered that the injury may have been caused by a defective product. These are important distinctions that may impact your legal rights.
If you or a loved one suffered a drug or medical device injury or a type of personal injury claim that we are investigating, we welcome the opportunity to talk with you.

Disclaimer: Submission of information to The Meneo Law Group does not establish an attorney-client relationship and should not be viewed or understood as doing so. An attorney-client relationship can only be established by the agreement of both the attorney and the client and must be reduced to a written retainer agreement that has been signed by both parties.

Learn about your LEGAL RIGHTS